These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 18505686)

  • 1. A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro.
    Winton MJ; Van Deerlin VM; Kwong LK; Yuan W; Wood EM; Yu CE; Schellenberg GD; Rademakers R; Caselli R; Karydas A; Trojanowski JQ; Miller BL; Lee VM
    FEBS Lett; 2008 Jun; 582(15):2252-6. PubMed ID: 18505686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
    Van Deerlin VM; Leverenz JB; Bekris LM; Bird TD; Yuan W; Elman LB; Clay D; Wood EM; Chen-Plotkin AS; Martinez-Lage M; Steinbart E; McCluskey L; Grossman M; Neumann M; Wu IL; Yang WS; Kalb R; Galasko DR; Montine TJ; Trojanowski JQ; Lee VM; Schellenberg GD; Yu CE
    Lancet Neurol; 2008 May; 7(5):409-16. PubMed ID: 18396105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies.
    Igaz LM; Kwong LK; Chen-Plotkin A; Winton MJ; Unger TL; Xu Y; Neumann M; Trojanowski JQ; Lee VM
    J Biol Chem; 2009 Mar; 284(13):8516-24. PubMed ID: 19164285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS and FTLD: two faces of TDP-43 proteinopathy.
    Liscic RM; Grinberg LT; Zidar J; Gitcho MA; Cairns NJ
    Eur J Neurol; 2008 Aug; 15(8):772-80. PubMed ID: 18684309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
    Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
    J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation.
    Winton MJ; Igaz LM; Wong MM; Kwong LK; Trojanowski JQ; Lee VM
    J Biol Chem; 2008 May; 283(19):13302-9. PubMed ID: 18305110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional complementation in Drosophila to predict the pathogenicity of TARDBP variants: evidence for a loss-of-function mechanism.
    Vanden Broeck L; Kleinberger G; Chapuis J; Gistelinck M; Amouyel P; Van Broeckhoven C; Lambert JC; Callaerts P; Dermaut B
    Neurobiol Aging; 2015 Feb; 36(2):1121-9. PubMed ID: 25442115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
    Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
    J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
    Prudlo J
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
    Ito D; Suzuki N
    Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS
    Wobst HJ; Wesolowski SS; Chadchankar J; Delsing L; Jacobsen S; Mukherjee J; Deeb TZ; Dunlop J; Brandon NJ; Moss SJ
    Front Mol Neurosci; 2017; 10():46. PubMed ID: 28286471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
    Rutherford NJ; Zhang YJ; Baker M; Gass JM; Finch NA; Xu YF; Stewart H; Kelley BJ; Kuntz K; Crook RJ; Sreedharan J; Vance C; Sorenson E; Lippa C; Bigio EH; Geschwind DH; Knopman DS; Mitsumoto H; Petersen RC; Cashman NR; Hutton M; Shaw CE; Boylan KB; Boeve B; Graff-Radford NR; Wszolek ZK; Caselli RJ; Dickson DW; Mackenzie IR; Petrucelli L; Rademakers R
    PLoS Genet; 2008 Sep; 4(9):e1000193. PubMed ID: 18802454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
    Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
    Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R
    Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD.
    Khosravi B; Hartmann H; May S; Möhl C; Ederle H; Michaelsen M; Schludi MH; Dormann D; Edbauer D
    Hum Mol Genet; 2017 Feb; 26(4):790-800. PubMed ID: 28040728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Janssens J; Kleinberger G; Wils H; Van Broeckhoven C
    Biochem Soc Trans; 2011 Aug; 39(4):954-9. PubMed ID: 21787329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.
    Geser F; Martinez-Lage M; Kwong LK; Lee VM; Trojanowski JQ
    J Neurol; 2009 Aug; 256(8):1205-14. PubMed ID: 19271105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of the TDP-43 deposition in FTLD-U and ALS].
    Hasegawa M; Arai T; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H
    Rinsho Shinkeigaku; 2008 Nov; 48(11):994-7. PubMed ID: 19198142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
    Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
    Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.